US 11207333
Compositions comprising triterpenoids and uses thereof for treating optic neuropathy
granted A61KA61K31/045A61K31/047
Quick answer
US patent 11207333 (Compositions comprising triterpenoids and uses thereof for treating optic neuropathy) held by REGENERA PHARMA LTD. expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERA PHARMA LTD.
- Grant date
- Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/045, A61K31/047, A61K31/19, A61K31/56